Point72 Middle East FZE’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,986
Closed -$231K 939
2023
Q4
$231K Sell
11,986
-3,498
-23% -$63.4K 0.01% 1018
2023
Q3
$250K Sell
15,484
-5,642
-27% -$100K 0.01% 970
2023
Q2
$402K Buy
+21,126
New +$377K 0.01% 840
2023
Q1
Sell
-287
Closed -$5.61K 2045
2022
Q4
$5.61K Buy
+287
New +$5.6K ﹤0.01% 1770

Other funds holding ACH

Point72 Middle East FZE's ACH Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Accendra Health (ACH) in Q1 2024, closing a stake of 11,986 shares — an estimated $231K sold.

Point72 Middle East FZE first reported a position in ACH in Q4 2022 and held it in 4 quarters. The position peaked at $402K in Q2 2023. 231 funds tracked by Wall St. Rank hold ACH as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Accendra Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 11,986 Accendra Health shares in Q1 2024, an estimated $231K.
  • Point72 Middle East FZE first reported a position in Accendra Health in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Accendra Health position peaked at $402K in Q2 2023.
  • 231 funds tracked by Wall St. Rank held Accendra Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.